Hybrid Chelator-Based PSMA Radiopharmaceuticals: Translational Approach
(1) Background: Prostate-specific membrane antigen (PSMA) has been extensively studied in the last decade. It became a promising biological target in the diagnosis and therapy of PSMA-expressing cancer diseases. Although there are several radiolabeled PSMA inhibitors available, the search for new co...
Guardado en:
| Autores principales: | , , , , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
MDPI AG
2021
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/a9eb4683b79f4443a8fc6edd6be9f631 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| Sumario: | (1) Background: Prostate-specific membrane antigen (PSMA) has been extensively studied in the last decade. It became a promising biological target in the diagnosis and therapy of PSMA-expressing cancer diseases. Although there are several radiolabeled PSMA inhibitors available, the search for new compounds with improved pharmacokinetic properties and simplified synthesis is still ongoing. In this study, we developed PSMA ligands with two different hybrid chelators and a modified linker. Both compounds have displayed a promising pharmacokinetic profile. (2) Methods: DATA<sup>5m</sup>.SA.KuE and AAZTA<sup>5</sup>.SA.KuE were synthesized. DATA<sup>5m</sup>.SA.KuE was labeled with gallium-68 and radiochemical yields of various amounts of precursor at different temperatures were determined. Complex stability in phosphate-buffered saline (PBS) and human serum (HS) was examined at 37 °C. Binding affinity and internalization ratio were determined in <i>in vitro</i> assays using PSMA-positive LNCaP cells. Tumor accumulation and biodistribution were evaluated <i>in vivo</i> and <i>ex vivo</i> using an LNCaP Balb/c nude mouse model. All experiments were conducted with PSMA-11 as reference. (3) Results: DATA<sup>5m</sup>.SA.KuE was synthesized successfully. AAZTA<sup>5</sup>.SA.KuE was synthesized and labeled according to the literature. Radiolabeling of DATA<sup>5m</sup>.SA.KuE with gallium-68 was performed in ammonium acetate buffer (1 M, pH 5.5). High radiochemical yields (>98%) were obtained with 5 nmol at 70 °C, 15 nmol at 50 °C, and 60 nmol (50 µg) at room temperature. [<sup>68</sup>Ga]Ga-DATA<sup>5m</sup>.SA.KuE was stable in human serum as well as in PBS after 120 min. PSMA binding affinities of AAZTA<sup>5</sup>.SA.KuE and DATA<sup>5m</sup>.SA.KuE were in the nanomolar range. PSMA-specific internalization ratio was comparable to PSMA-11. <i>In vivo</i> and <i>ex vivo</i> studies of [<sup>177</sup>Lu]Lu-AAZTA<sup>5</sup>.SA.KuE, [<sup>44</sup>Sc]Sc-AAZTA<sup>5</sup>.SA.KuE and [<sup>68</sup>Ga]Ga-DATA<sup>5m</sup>.SA.KuE displayed specific accumulation in the tumor along with fast clearance and reduced off-target uptake. (4) Conclusions: Both KuE-conjugates showed promising properties especially <i>in vivo</i> allowing for translational theranostic use. |
|---|